Table 3.
Patient demographics in explorative prognostic study at baseline
| Parameter | N (%) | Median (IQR) | |
|---|---|---|---|
| Sex | Women | 5 (17.9%) | |
| Men | 23 (82.1%) | ||
| Age (years) | 71.5 (9.4) | ||
| Body mass index | 27.7 (7.2) | ||
| Smoker | Never | 2 (7.1%) | |
| Past | 17 (60.7%) | ||
| Current | 9 (32.1%) | ||
| Nicotine pack-years | 34.0 (27.0) | ||
| AAA family history | 2 (7.1%) | ||
| Maximum AAA diameter (mm) | 50.8 (10.4) | ||
| Aneurysm volume (cm3) | 99.9 (60.6) | ||
| Maximum ILT thickness (mm) | 17.1 (16.9) | ||
| Hypertension | 24 (85.7%) | ||
| Hyperlipidaemia | 26 (92.9%) | ||
| PAD | 7 (25.0%) | ||
| Coronary heart disease | 12 (42.9%) | ||
| Myocardial infarction | 7 (25.0%) | ||
| Stroke | 4 (14.3%) | ||
| Diabetes mellitus | 9 (32.1%) | ||
| COPD | 8 (28.6%) | ||
| Anti-platelet therapy | 26 (92.9%) | ||
| Anti-hypertensive therapy | 23 (82.1%) | ||
| Lipid-lowering agents | 24 (85.7%) | ||
AAA abdominal aortic aneurysm, COPD chronic obstructive pulmonary disease, ILT intraluminal thrombus, IQR interquartile range, PAD peripheral artery occlusive disease